Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 9
Submit an article Journal homepage
7,279
Views
31
CrossRef citations to date
0
Altmetric
Review

Swedish Inflammatory Bowel Disease Register (SWIBREG) – a nationwide quality register

Jonas F. LudvigssonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; ;Department of Pediatrics, Örebro University Hospital, Örebro, Sweden; ;Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK; ;Department of Medicine, Celiac Disease Center, Columbia University College of Physicians and Surgeons, New York, NY, USA; View further author information
,
Marie AnderssonDepartment of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden; View further author information
,
Jonas BengtssonDepartment of Surgery, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden; View further author information
,
Michael EberhardsonDepartment of Medicine, Karolinska Institutet, Stockholm, Sweden; View further author information
,
Ulrika L. FagerbergCenter for Clinical Research, Västmanland Hospital, Västerås, Sweden and Uppsala University, Uppsala, Sweden; ;Department of Pediatrics, Västmanland Hospital, Västerås, Sweden; ;Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden; View further author information
,
Olof GripDepartment of Gastroenterology, Skåne University Hospital, Malmö, Sweden; View further author information
,
Jonas HalfvarsonDepartment of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; View further author information
,
Henrik HjortswangDepartment of Gastroenterology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; View further author information
,
Susanna JäghultStockholm Gastro Center, Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden; View further author information
,
Pontus KarlingDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
,
Caroline NordenvallDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; ;Department of Colorectal Cancer, Karolinska University Hospital, Stockholm, Sweden; View further author information
,
Ola OlénSachs’ Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden; ;Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; ;Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; View further author information
,
Malin OlssonDepartment of Surgery, County Council of Östergötland, Linköping, Sweden; View further author information
,
Martin RejlerDepartment of Medicine, Höglandssjukhuset Eksjö, Region Jönköping County Council, Jönköping, Sweden; ;Jönköping Academy for Improvement of Health and Welfare, Jönköping University, Jönköping, Sweden; View further author information
,
Hans StridDepartment of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden; View further author information
&
Pär MyrelidDepartment of Surgery, County Council of Östergötland, Linköping, Sweden; ;Department of Clinical and Experimental Medicine, Faculty of Health, Linköping University, Linköping, SwedenCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7518-9213View further author information
ORCID Icon show all
Pages 1089-1101 | Received 22 Jun 2019, Accepted 22 Aug 2019, Published online: 09 Sep 2019

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Natalia Mouratidou, Petter Malmborg, Jacob Järås, Vignir Sigurdsson, Olof Sandström, Ulrika L Fagerberg, Gabriella Bröms, Jonas F Ludvigsson & Ola Olén. (2022) Identification of Childhood-Onset Inflammatory Bowel Disease in Swedish Healthcare Registers: A Validation Study. Clinical Epidemiology 14, pages 591-600.
Read now
Marije Boks, Mikael Lilja, Micael Widerström, Pontus Karling, Anna Lindam, Axel Eriksson & Malin Sjöström. (2022) Increased incidence of late-onset inflammatory bowel disease and microscopic colitis after a Cryptosporidium hominis outbreak. Scandinavian Journal of Gastroenterology 57:12, pages 1443-1449.
Read now
Anders Forss, Mark Clements, Pär Myrelid, Hans Strid, Charlotte Söderman, Agnieszka Wagner, David Andersson, Fredrik Hjelm, Ola Olén, Jonas F. Ludvigsson & Jonas Halfvarson. (2021) Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn’s disease (PROSE): a 16-week follow-up. Scandinavian Journal of Gastroenterology 56:6, pages 680-686.
Read now
Isak Östlund, Mårten Werner & Pontus Karling. (2021) Self-monitoring with home based fecal calprotectin is associated with increased medical treatment. A randomized controlled trial on patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 56:1, pages 38-45.
Read now
Jordan E Axelrad, Michael C Sachs, Jonas F Ludvigsson & Ola Olén. (2020) A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data. Clinical Epidemiology 12, pages 1059-1072.
Read now
Sarita Shrestha, Ola Olén, Carl Eriksson, Åsa H. Everhov, Pär Myrelid, Isabella Visuri, Jonas F. Ludvigsson, Ida Schoultz, Scott Montgomery, Michael C. Sachs, Jonas Halfvarson, Malin Olsson, Henrik Hjortswang, Jonas Bengtsson, Hans Strid, Marie Andersson, Susanna Jäghult, Michael Eberhardson, Caroline Nordenvall, Jan Björk, Ulrika L. Fagerberg, Martin Rejler, Olof Grip, Pontus Karling, Mattias Block, Eva Angenete, Per M. Hellström & Anders Gustavsson. (2020) The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register. Scandinavian Journal of Gastroenterology 55:4, pages 430-435.
Read now

Articles from other publishers (25)

Carl Eriksson, Jiangwei Sun, Matti Bryder, Gabriella Bröms, Åsa H. Everhov, Anders Forss, Tomas Jernberg, Jonas F. Ludvigsson & Ola Olén. (2024) Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics 59:9, pages 1122-1133.
Crossref
Karl Mårild, Jonas Söderling, Olof Stephansson, Jordan Axelrad, Jonas Halfvarson, Gabriella Bröms, Jan Marsal, Ola Olén & Jonas F. Ludvigsson. (2024) Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide Study. Gastroenterology 166:5, pages 802-814.e18.
Crossref
N. Lamichhane, N. Melas, V. Bergqvist, N.-P. Ekholm, O. Olén, J. F. Ludvigsson, H. Hjortswang, J. Marsal, C. Eriksson & J. Halfvarson. (2024) Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive Diseases and Sciences.
Crossref
Karl Mårild, Jonas Söderling, Jordan Axelrad, Jonas Halfvarson, Anders Forss, Ola Olén, Jonas F. Ludvigsson, Malin Olsson, Pär Myrelid, Henrik Hjortswang, Jonas Bengtsson, Hans Strid, Marie Andersson, Susanna Jäghult, Michael Eberhardson, Caroline Nordenvall, Jan Björk, Martin Rejler, Olof Grip, Ulrika L. Fagerberg & Pontus Karling. (2024) Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study. Clinical Gastroenterology and Hepatology 22:4, pages 831-846.
Crossref
Jack Latteur, Olivia Ernstsson, Evalill Nilsson, Susanna Jäghult & Emelie Heintz. (2024) Construct validity of EQ-5D-5L among patients with inflammatory bowel disease—a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry. Journal of Patient-Reported Outcomes 8:1.
Crossref
Egle Kvedaraite, Magda Lourda, Natalia Mouratidou, Tim Düking, Avinash Padhi, Kirsten Moll, Paulo Czarnewski, Indranil Sinha, Ioanna Xagoraris, Efthymia Kokkinou, Anastasios Damdimopoulos, Whitney Weigel, Olga Hartwig, Telma E. Santos, Tea Soini, Aline Van Acker, Nelly Rahkonen, Malin Flodström Tullberg, Emma Ringqvist, Marcus Buggert, Carl Jorns, Ulrik Lindforss, Caroline Nordenvall, Christopher T. Stamper, David Unnersjö-Jess, Mira Akber, Ruta Nadisauskaite, Jessica Jansson, Niels Vandamme, Chiara Sorini, Marijke Elise Grundeken, Helena Rolandsdotter, George Rassidakis, Eduardo J. Villablanca, Maja Ideström, Stefan Eulitz, Henrik Arnell, Jenny Mjösberg, Jan-Inge Henter & Mattias Svensson. (2024) Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF. Nature Communications 15:1.
Crossref
Tilman Sauerbruch, Sara Reinartz Groba & Alexander di Liberto. 2024. Therapie-Handbuch - Gastroenterologie und Hepatologie. Therapie-Handbuch - Gastroenterologie und Hepatologie 596 618 .
Åsa H. Everhov, Jonas Söderling, Gustaf Befrits, Hamed Khalili, Gabriella Bröms, Martin Neovius, Johan Askling, Jonas Halfvarson, Jonas F. Ludvigsson & Ola Olén. (2023) Increasing healthcare costs in inflammatory bowel disease 2007–2020 in Sweden. Alimentary Pharmacology & Therapeutics 58:7, pages 692-703.
Crossref
Carl Eriksson, Jonas Söderling, Sara Karlqvist, Gabriella Bröms, Åsa H. Everhov, Daniel Bergemalm, Jonas F. Ludvigsson, Ola Olén & Jonas Halfvarson. (2023) Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease. Digestive Diseases and Sciences 68:7, pages 3119-3128.
Crossref
Aiva Lundberg Båve, Ola Olén, Jonas Söderling, Jonas F. Ludvigsson, Annika Bergquist & Caroline Nordenvall. (2023) Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis. United European Gastroenterology Journal 11:5, pages 471-481.
Crossref
Efthymia Kokkinou, Tea Soini, Ram Vinay Pandey, Aline van Acker, Jakob Theorell, Paulo Czarnewski, Egle Kvedaraite, Niels Vandamme, Magda Lourda, Chiara Sorini, Whitney Weigel, Anna Carrasco, Christopher Andrew Tibbitt, Heinrich Schlums, Ulrik Lindforss, Caroline Nordenvall, Malin Ljunggren, Maja Ideström, Mattias Svensson, Jan-Inge Henter, Eduardo J. Villablanca, Yenan T. Bryceson, Helena Rolandsdotter & Jenny Mjösberg. (2023) The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis. Cell Reports Medicine, pages 101038.
Crossref
Daniel Deutscher, Clara Weil, Gabriel Chodick, Sveta Tsukinovsky, Keith Bodger, Matti Waterman & Revital Kariv. (2023) Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validity. Health and Quality of Life Outcomes 21:1.
Crossref
Aditi Kumar, Nuha Yassin, Alexandra Marley, Vittoria Bellato, Caterina Foppa, Gianluca Pellino, Pär Myrelid, Monica Millan, Beatriz Gros, Nicolas Avellaneda, Ignacio Catalan-Serra, Alaa El-Hussuna, João A. Cunha Neves, Joana Roseira, Miguel F. Cunha, Bram Verstockt, Dominik Bettenworth, Diane Mege & Matthew J. Brookes. (2023) Crossing barriers: the burden of inflammatory bowel disease across Western Europe. Therapeutic Advances in Gastroenterology 16.
Crossref
Anders Forss, Mark Clements, Pär Myrelid, Hans Strid, Charlotte Söderman, Agnieszka Wagner, David Andersson, Fredrik Hjelm, Ola Olén, Jonas Halfvarson & Jonas F. Ludvigsson. (2022) Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease. Digestive Diseases and Sciences 68:1, pages 65-76.
Crossref
Sarita Shrestha, Judith S Brand, Jacob Järås, Ida Schoultz, Scott Montgomery, Johan Askling, Jonas F Ludvigsson, Ola Olen, Jonas Halfvarson, Malin Olsson, Henrik Hjortswang, Par Myrelid, Jonas Bengtsson, Hans Strid, Marie Andersson, Susanna Jäghult, Michael Eberhardson, Caroline Nordenvall, Ulrika L Fagerberg, Martin Rejler, Olof Grip & Pontus Karling. (2022) Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden. Journal of Crohn's and Colitis 16:10, pages 1540-1550.
Crossref
Karl Mårild, Jonas Söderling, Olof Stephansson, Jordan Axelrad, Jonas Halfvarson, Gabriella Bröms, Jan Marsal, Ola Olén & Jonas F. Ludvigsson. (2022) Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study. eClinicalMedicine 53, pages 101722.
Crossref
Bharati Kochar, Juulia Jylhävä, Jonas Söderling, Christine S. Ritchie, Jonas F. Ludvigsson, Hamed Khalili, Ola Olén, Malin Olsson, Henrik Hjortswang, Pär Myrelid, Jonas Bengtsson, Hans Strid, Marie Andersson, Susanna Jäghult, Michael Eberhardson, Caroline Nordenvall, Jan Björk, Ulrika L. Fagerberg, Martin Rejler, Olof Grip, Pontus Karling & Jonas Halfvarson. (2022) Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study. Clinical Gastroenterology and Hepatology 20:10, pages 2358-2365.e11.
Crossref
Joel Thunberg, Olle Björkqvist, Charlotte R. H. Hedin, Anders Forss, Charlotte Söderman, Daniel Bergemalm, Ola Olén, Henrik Hjortswang, Hans Strid, Jonas F. Ludvigsson, Carl Eriksson & Jonas Halfvarson. (2022) Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal 10:7, pages 631-639.
Crossref
Michael Eberhardson, Pär Myrelid, Jonas K. Söderling, Anders Ekbom, Åsa H. Everhov, Charlotte R. H. Hedin, Martin Neovius, Jonas F. Ludvigsson & Ola Olén. (2022) Tumour necrosis factor inhibitors in Crohn's disease and the effect on surgery rates. Colorectal Disease 24:4, pages 470-483.
Crossref
Isabella Visuri, Carl Eriksson, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid, Jonas F. Ludvigsson & Jonas Halfvarson. (2021) Predictors of drug survival: A cohort study comparing anti‐tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register. Alimentary Pharmacology & Therapeutics 54:7, pages 931-943.
Crossref
Aiva Lundberg Båve, Annika Bergquist, Matteo Bottai, Anna Warnqvist, Erik von Seth & Caroline Nordenvall. (2021) Increased risk of cancer in patients with primary sclerosing cholangitis. Hepatology International 15:5, pages 1174-1182.
Crossref
Isabella Visuri, Carl Eriksson, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid, Jonas F. Ludvigsson & Jonas Halfvarson. (2021) Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply. Alimentary Pharmacology & Therapeutics 54:6, pages 848-849.
Crossref
Sara Rundquist, Michael C. Sachs, Carl Eriksson, Ola Olén, Scott Montgomery & Jonas Halfvarson. (2020) Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers. Alimentary Pharmacology & Therapeutics 53:4, pages 471-483.
Crossref
J. Davies, O. D. Faiz & S. R. Brown. (2021) Patient and clinician national registry synergy to enhance quality improvement in United Kingdom IBD surgery – is there appetite?. Colorectal Disease 23:1, pages 5-6.
Crossref
David Jacobs. (2019) ‘Old but Gold’ – Insights About Anti-TNF-α Therapy in the Treatment of Inflammatory Bowel Disease. EMJ Gastroenterology, pages 35-38.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.